GlobeNewsWire
24 Nov 2025, 18:59 UTC · 50w ago
Impact · against what's priced in
SMTI faces increased regulatory and litigation risk following a strategic realignment and business unit discontinuation. ELTX and NMRA are also under investigation for securities law compliance, adding negative overhead to their risk profiles.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish
Sanara MedTech Inc. (SMTI) has discontinued operations of its Tissue Health Plus division as part of a strategic realignment.
More negative than 93% of claims this week
Holzer & Holzer, LLC is investigating whether Sanara MedTech Inc. complied with federal securities laws following the realignment announcement.
Continue reading
5 related stories
The company is under investigation by Holzer & Holzer following a stock price drop triggered by the discontinuation of its Tissue Health Plus division.
Read from the article alone
No priced-in read yet
The company is being investigated for potential non-compliance with federal securities laws.
Read from the article alone
No priced-in read yet
The company is being investigated for potential non-compliance with federal securities laws.
Read from the article alone
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 83% of claims this week
Which stocks this story touches
More negative than 93% of ticker scores this week
The company is under investigation by a law firm following a stock price drop and the discontinuation of a business unit.
More negative than 86% of ticker scores this week
The company is being investigated by a law firm regarding compliance with federal securities laws.
More negative than 86% of ticker scores this week
The company is being investigated by a law firm regarding compliance with federal securities laws.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
3h ago
−81.5%
Price agrees with the score
$1.56 vs $8.45 close before publication (Nov 21) · not market-adjusted
ELTX chart →−80.0%
Price agrees with the score
$0.4664 vs $2.33 close before publication (Nov 21) · not market-adjusted
NMRA chart →+62.9%
Price is moving against the score
$31.73 vs $19.48 close before publication (Nov 21) · not market-adjusted
SMTI chart →
